LPV-90873-51331
4 vaccinations
2 coded responses
35 check-ins
2 free-text entries
2 call cases
- Sex
- —
- Age at first dose
- 31-35
- ZIP prefix
- 222 / VA
- Registered
- 2020-12-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
6KN-31026-15235
Child or adolescent in my care · Female · 2022-07-09
Timeline
-
2020-12-31
Registered in v-safe
-
2020-12-31
Dose 1 — Pfizer-BioNTech
-
2020-12-31
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Chills, Headache, NauseaAdult check-in
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-07
- 2021-01-16
-
2021-01-19
Dose 2 — Pfizer-BioNTech
- 2021-01-28
- 2021-02-02
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-04-22
- 2021-07-22
-
2021-10-08
Dose 3 — Pfizer-BioNTech
- 2021-10-16
- 2021-10-24
- 2021-10-29
- 2021-11-05
-
2021-11-13
Survey response — day 35, dose 3MedDRA: Abortion spontaneous — Feeling: Poor · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: MiscarriageMedDRA releases: 2024-11 · check-in free text available
-
2021-11-13
Report sent to call center — day 35, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-11-15
Call successfulCompleted over the phone
- 2021-11-19
- 2022-01-09
-
2022-04-08
Survey response — 6 months, dose 3MedDRA: Blood thyroid stimulating hormone increased, Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Pregnancy, elevated TSHMedDRA releases: 2024-11 · check-in free text available
-
2022-04-08
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-04-12
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-10-04
Dose 4 — Pfizer-BioNTech
- 2022-10-04
- 2022-10-06
- 2022-10-07
- 2022-10-08
- 2022-10-10
- 2022-10-11
- 2022-10-19
- 2022-10-25
- 2022-11-08
- 2022-11-15
- 2023-01-03
- 2023-04-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-31 | Pfizer-BioNTech | |
| 2 | 2021-01-19 | Pfizer-BioNTech | |
| 3 | 2021-10-08 | Pfizer-BioNTech | No |
| 4 | 2022-10-04 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-11-13 | Successful 2021-11-15 |
Completed over the phone |
| 2022-04-08 | Successful 2022-04-12 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 10 — day 35, dose 3
Symptoms: Miscarriage
Release 11 — 6 months, dose 3
Symptoms: Pregnancy, elevated TSH
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Blood thyroid stimulating hormone increased | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release